Literature DB >> 16331253

F-box protein Skp2: a novel transcriptional target of E2F.

L Zhang1, C Wang.   

Abstract

The F-box-containing protein Skp2 plays a critical role in coordinating the G1/S transition and progression through the S phase of the mammalian cell cycle. Skp2 is overexpressed in a broad spectrum of human cancers and the expression level correlates with tumor malignancy. However, the Skp2 gene is neither amplified nor rearranged in most human cancers and the underlying mechanism of Skp2 overexpression remains poorly understood. We show here that the Skp2 gene contains a functional E2F response element (hSRE2). Ectopic expression of E2F1 induces expression of the endogenous Skp2 gene in human fibroblast cells, whereas antisense-mediated knockdown of E2F1 in human tumor cell lines reduces expression of endogenous Skp2 gene. The hSRE2 element not only participates in activation of Skp2 promoter function during normal cell cycle progression into S phase, it is also required for the high-level Skp2 gene expression in many human tumor cell lines. These results reveal Skp2 as a novel target for E2F regulation that is disrupted in several human tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16331253      PMCID: PMC1513044          DOI: 10.1038/sj.onc.1209286

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

1.  Myc degradation: dancing with ubiquitin ligases.

Authors:  Bruno Amati
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-08       Impact factor: 11.205

Review 2.  Molecular mechanisms of E2F-dependent activation and pRB-mediated repression.

Authors:  Maxim V Frolov; Nicholas J Dyson
Journal:  J Cell Sci       Date:  2004-05-01       Impact factor: 5.285

3.  Crashing waves of destruction: the cell cycle and APC(Cdh1) regulation of SCF(Skp2).

Authors:  John F Kurland; William P Tansey
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

4.  A general method for isolation of high molecular weight DNA from eukaryotes.

Authors:  N Blin; D W Stafford
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

5.  Immunoglobulin heavy-chain enhancer requires one or more tissue-specific factors.

Authors:  M Mercola; J Goverman; C Mirell; K Calame
Journal:  Science       Date:  1985-01-18       Impact factor: 47.728

6.  Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.

Authors:  E Lees; B Faha; V Dulic; S I Reed; E Harlow
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

7.  Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein.

Authors:  K Helin; E Harlow; A Fattaey
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

8.  The transcription factor E2F-1 is a downstream target of RB action.

Authors:  X Q Qin; D M Livingston; M Ewen; W R Sellers; Z Arany; W G Kaelin
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

9.  A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex.

Authors:  S H Devoto; M Mudryj; J Pines; T Hunter; J R Nevins
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

10.  Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes.

Authors:  Sana Yokoi; Kohichiroh Yasui; Miki Mori; Toshihiko Iizasa; Takehiko Fujisawa; Johji Inazawa
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

View more
  64 in total

1.  Androgens repress expression of the F-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells.

Authors:  Jingting Jiang; Yunqian Pan; Kevin M Regan; Changping Wu; Xueguang Zhang; Donald J Tindall; Haojie Huang
Journal:  Prostate       Date:  2011-05-31       Impact factor: 4.104

2.  Regulation of the DNA damage response by p53 cofactors.

Authors:  Xiao-Peng Zhang; Feng Liu; Wei Wang
Journal:  Biophys J       Date:  2012-05-15       Impact factor: 4.033

3.  APC/C(Cdc20) targets E2F1 for degradation in prometaphase.

Authors:  Melissa J Peart; Masha V Poyurovsky; Elizabeth M Kass; Marshall Urist; Emmy W Verschuren; Matthew K Summers; Peter K Jackson; Carol Prives
Journal:  Cell Cycle       Date:  2010-10-26       Impact factor: 4.534

4.  Acetylation-dependent regulation of Skp2 function.

Authors:  Hiroyuki Inuzuka; Daming Gao; Lydia W S Finley; Wen Yang; Lixin Wan; Hidefumi Fukushima; Y Rebecca Chin; Bo Zhai; Shavali Shaik; Alan W Lau; Zhiwei Wang; Steven P Gygi; Keiko Nakayama; Julie Teruya-Feldstein; Alex Toker; Marcia C Haigis; Pier Paolo Pandolfi; Wenyi Wei
Journal:  Cell       Date:  2012-07-06       Impact factor: 41.582

5.  Skp2 knockout reduces cell proliferation and mouse body size: and prevents cancer?

Authors:  Liang Zhu
Journal:  Cell Res       Date:  2010-05-25       Impact factor: 25.617

Review 6.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

7.  ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets.

Authors:  Jessie Villanueva; Yuval Yung; Janice L Walker; Richard K Assoian
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

8.  Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.

Authors:  J Wu; S-W Lee; X Zhang; F Han; S-Y Kwan; X Yuan; W-L Yang; Y S Jeong; A H Rezaeian; Y Gao; Y-X Zeng; H-K Lin
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

9.  WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.

Authors:  Yaxiong Tang; Anne R Simoneau; Wu-xiang Liao; Guo Yi; Christopher Hope; Feng Liu; Shunqiang Li; Jun Xie; Randall F Holcombe; Frances A Jurnak; Dan Mercola; Bang H Hoang; Xiaolin Zi
Journal:  Mol Cancer Ther       Date:  2009-01-27       Impact factor: 6.261

Review 10.  p53 and E2f: partners in life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.